List of works - Björn Stollenwerk

A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet.

scientific article published on 2 February 2018

A Model for Assessing the Clinical and Economic Benefits of Bone-forming Agents for Reducing Fractures in Postmenopausal Women at High, Near-term Risk of Osteoporotic Fracture

scientific article published on 16 June 2017

A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting

scientific article

A systematic review of the quality of economic models comparing thrombosis inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention

scientific article

Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation.

scientific article published on 30 December 2012

Breast cancer attributable costs in Germany: a top-down approach based on sickness funds data

scientific article

C-reactive protein levels and post-ICU mortality in nonsurgical intensive care patients.

scientific article

Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makers

scientific article published on 4 March 2014

Cost effectiveness of external hip protectors in the hospital setting: a modeling study

scientific article published in March 2014

Cost effectiveness of rivaroxaban for stroke prevention in German patients with atrial fibrillation.

scientific article published on March 2015

Cost-Effectiveness Analysis of Ugt1a1 Genotyping Before Colorectal Cancer Treatment with Irinotecan

scientific article published on 26 October 2014

Cost-Effectiveness of an Individualized First-Line Treatment Strategy Offering Erlotinib Based on EGFR Mutation Testing in Advanced Lung Adenocarcinoma Patients in Germany.

scientific article

Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homes

scientific article published on 13 May 2014

Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model

scientific article published on 9 January 2015

Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach

scientific article

Costs and effects of intra-operative fluorescence molecular imaging - A model-based, early assessment.

scientific article

Depression-related treatment and costs in Germany: Do they change with comorbidity? A claims data analysis.

scientific article

Economic evaluation of genetic screening for Lynch syndrome in Germany.

scientific article published on 8 January 2015

Effects of a 3-year nurse-based case management in aged patients with acute myocardial infarction on rehospitalisation, mortality, risk factors, physical functioning and mental health. a secondary analysis of the randomized controlled KORINNA study

scientific article

Effects of a nurse-based case management compared to usual care among aged patients with myocardial infarction: results from the randomized controlled KORINNA study

scientific article

Exploring the potential value of improved care for secondary hyperparathyroidism with a novel calcimimetic therapy.

scientific article published on 14 August 2017

Financial incentives in the German Statutory Health Insurance: new findings, new questions.

scientific article

Limited Economic Evidence of Carotid Artery Stenosis Diagnosis and Treatment: A Systematic Review ⬇️

scientific article published on September 18, 2012

Link between process and appraisal in coverage decisions: an analysis with structural equation modeling

scientific article published on 14 June 2013

Longterm persistence and nonrecurrence of depression treatment in Germany: a four-year retrospective follow-up using linked claims data.

scientific article published on 15 February 2018

Preliminary analysis of short-term financial implications of a prevention bonus program: first results from the German Statutory Health Insurance

scientific article published in January 2008

Prioritization of Future Outcomes Research Studies in Chronic Myeloid Leukemia: Value of Information Analysis.

scientific article published on 26 October 2014

Prognostic value and clinical effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events

scientific article published in January 2009

Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events

scientific article

Progression-free survival as a surrogate endpoint in advanced breast cancer

scientific article published on January 2008

Reporting health care decision models: a prospective reliability study of a multidimensional evaluation framework

scientific article published on 7 November 2015

Safety of Bevacizumab in Patients with Advanced Cancer: A Meta-Analysis of Randomized Controlled Trials

scholarly article published in Oncologist

Safety of bevacizumab in patients with advanced cancer: a meta-analysis of randomized controlled trials.

scientific article

Serum antibodies against Saccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinoma.

scientific article

Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance.

scientific article published on April 2008

Should health insurers target prevention of cardiovascular disease? A cost-effectiveness analysis of an individualised programme in Germany based on routine data

scientific article

The German Coronary Artery Disease Risk Screening Model: development, validation, and application of a decision-analytic model for coronary artery disease prevention with statins

scientific article published on 22 September 2009

The association between health system development and the burden of cardiovascular disease: an analysis of WHO country profiles

scientific article

The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance

scientific article published on 22 June 2015

The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer.

scientific article

The effectiveness of the cardiovascular disease prevention programme 'KardioPro' initiated by a German sickness fund: a time-to-event analysis of routine data

scientific article

The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention

scientific article published on 24 January 2015

Transparency vs. closed-door policy: do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis

scientific article published on 10 May 2013

Uncertainty assessment of input parameters for economic evaluation: Gauss's error propagation, an alternative to established methods

scientific article published on 08 October 2009

Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation

scientific article

Waiting times for elective treatments according to insurance status: A randomized empirical study in Germany.

scientific article

[Cost-effectiveness of prevention of coronary disease in Germany]

scientific article published on 01 January 2005

List of works by Björn Stollenwerk

A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet.

A Model for Assessing the Clinical and Economic Benefits of Bone-forming Agents for Reducing Fractures in Postmenopausal Women at High, Near-term Risk of Osteoporotic Fracture

A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting

A systematic review of the quality of economic models comparing thrombosis inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention

Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation.

Breast cancer attributable costs in Germany: a top-down approach based on sickness funds data

C-reactive protein levels and post-ICU mortality in nonsurgical intensive care patients.

Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makers

Cost effectiveness of external hip protectors in the hospital setting: a modeling study

Cost effectiveness of rivaroxaban for stroke prevention in German patients with atrial fibrillation.

Cost-Effectiveness Analysis of Ugt1a1 Genotyping Before Colorectal Cancer Treatment with Irinotecan

Cost-Effectiveness of an Individualized First-Line Treatment Strategy Offering Erlotinib Based on EGFR Mutation Testing in Advanced Lung Adenocarcinoma Patients in Germany.

Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homes

Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model

Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach

Costs and effects of intra-operative fluorescence molecular imaging - A model-based, early assessment.

Depression-related treatment and costs in Germany: Do they change with comorbidity? A claims data analysis.

Economic evaluation of genetic screening for Lynch syndrome in Germany.

Effects of a 3-year nurse-based case management in aged patients with acute myocardial infarction on rehospitalisation, mortality, risk factors, physical functioning and mental health. a secondary analysis of the randomized controlled KORINNA study

Effects of a nurse-based case management compared to usual care among aged patients with myocardial infarction: results from the randomized controlled KORINNA study

Exploring the potential value of improved care for secondary hyperparathyroidism with a novel calcimimetic therapy.

Financial incentives in the German Statutory Health Insurance: new findings, new questions.

Limited Economic Evidence of Carotid Artery Stenosis Diagnosis and Treatment: A Systematic Review ⬇️

Link between process and appraisal in coverage decisions: an analysis with structural equation modeling

Longterm persistence and nonrecurrence of depression treatment in Germany: a four-year retrospective follow-up using linked claims data.

Preliminary analysis of short-term financial implications of a prevention bonus program: first results from the German Statutory Health Insurance

Prioritization of Future Outcomes Research Studies in Chronic Myeloid Leukemia: Value of Information Analysis.

Prognostic value and clinical effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events

Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events

Progression-free survival as a surrogate endpoint in advanced breast cancer

Reporting health care decision models: a prospective reliability study of a multidimensional evaluation framework

Safety of Bevacizumab in Patients with Advanced Cancer: A Meta-Analysis of Randomized Controlled Trials

Safety of bevacizumab in patients with advanced cancer: a meta-analysis of randomized controlled trials.

Serum antibodies against Saccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinoma.

Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance.

Should health insurers target prevention of cardiovascular disease? A cost-effectiveness analysis of an individualised programme in Germany based on routine data

The German Coronary Artery Disease Risk Screening Model: development, validation, and application of a decision-analytic model for coronary artery disease prevention with statins

The association between health system development and the burden of cardiovascular disease: an analysis of WHO country profiles

The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance

The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer.

The effectiveness of the cardiovascular disease prevention programme 'KardioPro' initiated by a German sickness fund: a time-to-event analysis of routine data

The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention

Transparency vs. closed-door policy: do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis

Uncertainty assessment of input parameters for economic evaluation: Gauss's error propagation, an alternative to established methods

Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation

Waiting times for elective treatments according to insurance status: A randomized empirical study in Germany.

[Cost-effectiveness of prevention of coronary disease in Germany]